Risk factors for radiocontrast nephropathy after emergency department contrast-enhanced computerized tomography

Academic Emergency Medicine

Volumn 20, Issue 1, 2013, Pages 40-45

  Traub, Stephen J ^a,b,c   Kellum, John A ^d   Tang, Aimee ^a   Cataldo, Lauren ^a   Kancharla, Adarsh ^a   Shapiro, Nathan I ^a,e  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c Mayo Clinic College of Medicine   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL DECISION MAKING; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; EMERGENCY WARD; FEMALE; GROUPS BY AGE; HEART FAILURE; HEMATOCRIT; HUMAN; HYPERTENSION; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; TERTIARY HEALTH CARE; VASCULAR DISEASE;

ACUTE KIDNEY INJURY; ADULT; AGED; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; CONTRAST MEDIA; EMERGENCY SERVICE, HOSPITAL; EMERGENCY TREATMENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; IODINE COMPOUNDS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; RADIOGRAPHIC IMAGE ENHANCEMENT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TERTIARY CARE CENTERS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84872356292     PISSN: 10696563     EISSN: 15532712     Source Type: Journal    
DOI: 10.1111/acem.12059     Document Type: Article

References (31)

1. Dangas G, Iakovou I, Nikolsky E, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol. 2005; 95: 13-9.
2. Conen D, Buerkle G, Perruchoud AP, Buettner HJ, Mueller C,. Hypertension is an independent risk factor for contrast nephropathy after percutaneous coronary intervention. Int J Cardiol. 2006; 110: 237-41.
3. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004; 44: 1393-9.
4. Solomon RJ, Mehran R, Natarajan MK, et al. Contrast-induced nephropathy and long-term adverse events: cause and effect? Clin J Am Soc Nephrol. 2009; 4: 1162-9.
5. Nash K, Hafeez A, Hou S,. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002; 39: 930-6.
6. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002; 105: 2259-64.
7. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW,. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997; 103: 368-75.
8. Gupta R, Gurm HS, Bhatt DL, Chew DP, Ellis SG,. Renal failure after percutaneous coronary intervention is associated with high mortality. Catheter Cardiovasc Interv. 2005; 64: 442-8.
9. Krol AL, Dzialowski I, Roy J, et al. Incidence of radiocontrast nephropathy in patients undergoing acute stroke computed tomography angiography. Stroke. 2007; 38: 2364-6.
10. Hopyan JJ, Gladstone DJ, Mallia G, et al. Renal safety of CT angiography and perfusion imaging in the emergency evaluation of acute stroke. AJNR Am J Neuroradiol. 2008; 29: 1826-30.
11. Dittrich R, Akdeniz S, Kloska SP, et al. Low rate of contrast-induced nephropathy after CT perfusion and CT angiography in acute stroke patients. J Neurol. 2007; 254: 1491-7.
12. Tremblay LN, Tien H, Hamilton P, et al. Risk and benefit of intravenous contrast in trauma patients with an elevated serum creatinine. J Trauma. 2005; 59: 1162-6.
13. Hipp A, Desai S, Lopez C, Sinert R,. The incidence of contrast-induced nephropathy in trauma patients. Eur J Emerg Med. 2008; 15: 134-9.
14. McGillicuddy EA, Schuster KM, Kaplan LJ, et al. Contrast-induced nephropathy in elderly trauma patients. J Trauma. 2010; 68: 294-7.
15. Kulvatunyou N, Rhee PM, Carter SN, et al. Defining incidence and outcome of contrast-induced nephropathy among trauma: is it overhyped? Am Surg. 2011; 77: 686-9.
16. Kim KS, Kim K, Hwang SS, et al. Risk stratification nomogram for nephropathy after abdominal contrast-enhanced computed tomography. Am J Emerg Med. 2011; 29: 412-7.
17. Mitchell AM, Kline JA,. Contrast nephropathy following computed tomography angiography of the chest for pulmonary embolism in the emergency department. J Thromb Haemost. 2007; 5: 50-4.
18. Kooiman J, Klok FA, Mos IC, et al. Incidence and predictors of contrast-induced nephropathy following CT-angiography for clinically suspected acute pulmonary embolism. J Thromb Haemost. 2010; 8: 409-11.
19. Mitchell AM, Jones AE, Tumlin JA, Kline JA,. Incidence of contrast-induced nephropathy after contrast-enhanced computed tomography in the outpatient setting. Clin J Am Soc Nephrol. 2010; 5: 4-9.
20. Poletti PA, Saudan P, Platon A, et al. I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity. AJR Am J Roentgenol. 2007; 189: 687-92.
21. Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int. 1995; 47: 254-61.
22. Lautin EM, Freeman NJ, Schoenfeld AH, et al. Radiocontrast-associated renal dysfunction: incidence and risk factors. AJR Am J Roentgenol. 1991; 157: 49-58.
23. Davidson CJ, Hlatky M, Morris KG, et al. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. Ann Intern Med. 1989; 110: 119-24.
24. Nikolsky E, Mehran R, Lasic Z, et al. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int. 2005; 67: 706-13.
25. Lodhia N, Kader M, Mayes T, Mantry P, Maliakkal B,. Risk of contrast-induced nephropathy in hospitalized patients with cirrhosis. World J Gastroenterol. 2009; 15: 1459-64.
26. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P,. Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs-The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004; 8: R204-12.
27. Newhouse JH, Kho D, Rao QA, Starren J,. Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol. 2008; 191: 376-82.
28. Bruce RJ, Djamali A, Shinki K, Michel SJ, Fine JP, Pozniak MA,. Background fluctuation of kidney function versus contrast-induced nephrotoxicity. AJR Am J Roentgenol. 2009; 192: 711-8.
29. Sinert R, Brandler E, Subramanian A, Miller AC,. Does the current definition of contrast-induced acute kidney injury reflect a true clinical entity? Acad Emerg Med. 2012; 19: 1261-7.
30. Mitchell AM, Kline JA,. Contrast-induced nephropathy: doubts and certainties. Acad Emerg Med. 2012; 19: 1294-6.
31. Sudarsky D, Nikolsky E,. Contrast-induced nephropathy in interventional cardiology. Int J Nephrol Renovasc Dis. 2011; 4: 85-99.